638 related articles for article (PubMed ID: 28599597)
21. CRISPR-Cas9-mediated gene disruption of HIV-1 co-receptors confers broad resistance to infection in human T cells and humanized mice.
Li S; Holguin L; Burnett JC
Mol Ther Methods Clin Dev; 2022 Mar; 24():321-331. PubMed ID: 35229006
[TBL] [Abstract][Full Text] [Related]
22. A simultaneous knockout knockin genome editing strategy in HSPCs potently inhibits CCR5- and CXCR4-tropic HIV-1 infection.
Dudek AM; Feist WN; Sasu EJ; Luna SE; Ben-Efraim K; Bak RO; Cepika AM; Porteus MH
Cell Stem Cell; 2024 Apr; 31(4):499-518.e6. PubMed ID: 38579682
[TBL] [Abstract][Full Text] [Related]
23. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.
Fais S; Lapenta C; Santini SM; Spada M; Parlato S; Logozzi M; Rizza P; Belardelli F
J Virol; 1999 Aug; 73(8):6453-9. PubMed ID: 10400739
[TBL] [Abstract][Full Text] [Related]
24. [Protection of Lymphocytes Against HIV using Lentivirus Vector Carrying a Combination of TRIM5α-HRH Genes and microRNA Against CCR5].
Omelchenko DO; Glazkova DV; Bogoslovskaya EV; Urusov FA; Zhogina YA; Tsyganova GM; Shipulin GA
Mol Biol (Mosk); 2018; 52(2):294-305. PubMed ID: 29695698
[TBL] [Abstract][Full Text] [Related]
25. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.
Grivel JC; Margolis LB
Nat Med; 1999 Mar; 5(3):344-6. PubMed ID: 10086394
[TBL] [Abstract][Full Text] [Related]
26. Purifying selection of CCR5-tropic human immunodeficiency virus type 1 variants in AIDS subjects that have developed syncytium-inducing, CXCR4-tropic viruses.
Fernàndez G; Llano A; Esgleas M; Clotet B; Esté JA; Martínez MA
J Gen Virol; 2006 May; 87(Pt 5):1285-1294. PubMed ID: 16603531
[TBL] [Abstract][Full Text] [Related]
27. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
[TBL] [Abstract][Full Text] [Related]
28. Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editing.
Knipping F; Newby GA; Eide CR; McElroy AN; Nielsen SC; Smith K; Fang Y; Cornu TI; Costa C; Gutierrez-Guerrero A; Bingea SP; Feser CJ; Steinbeck B; Hippen KL; Blazar BR; McCaffrey A; Mussolino C; Verhoeyen E; Tolar J; Liu DR; Osborn MJ
Mol Ther; 2022 Jan; 30(1):130-144. PubMed ID: 34737067
[TBL] [Abstract][Full Text] [Related]
29. Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection.
Hou P; Chen S; Wang S; Yu X; Chen Y; Jiang M; Zhuang K; Ho W; Hou W; Huang J; Guo D
Sci Rep; 2015 Oct; 5():15577. PubMed ID: 26481100
[TBL] [Abstract][Full Text] [Related]
30. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
31. Increased number of CCR5+ CD4 T cells among south Indian adults probably associated with the low frequency of X4 phenotype of HIV-1 in India.
Ramalingam S; Kannangai R; Vijayakumar TS; Subramanian S; Abraham OC; Rupali P; Jesudason MV; Sridharan G
Indian J Med Res; 2002 Sep; 116():90-5. PubMed ID: 12619446
[TBL] [Abstract][Full Text] [Related]
32. Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.
Bunnik EM; Quakkelaar ED; van Nuenen AC; Boeser-Nunnink B; Schuitemaker H
J Virol; 2007 Jan; 81(2):525-31. PubMed ID: 17079299
[TBL] [Abstract][Full Text] [Related]
33. Dual-tropic HIV type 1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptors.
Toma J; Whitcomb JM; Petropoulos CJ; Huang W
AIDS; 2010 Sep; 24(14):2181-6. PubMed ID: 20639728
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 replication in CD4+ T cell lines: the effects of adaptation on co-receptor use, tropism, and accessory gene function.
Dejucq N
J Leukoc Biol; 2000 Sep; 68(3):331-7. PubMed ID: 10985248
[TBL] [Abstract][Full Text] [Related]
35. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
Chen Z; Gettie A; Ho DD; Marx PA
Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
[TBL] [Abstract][Full Text] [Related]
36. A recombinant vesicular stomatitis virus encoding CCR5-tropic HIV-1 receptors targets HIV-1-infected cells and controls HIV-1 infection.
Okuma K; Fukagawa K; Kohma T; Takahama Y; Hamaguchi Y; Ito M; Tanaka Y; Buonocore L; Rose JK; Hamaguchi I
Microbes Infect; 2017; 19(4-5):277-287. PubMed ID: 28025070
[TBL] [Abstract][Full Text] [Related]
37. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines.
Juffermans NP; Paxton WA; Dekkers PE; Verbon A; de Jonge E; Speelman P; van Deventer SJ; van der Poll T
Blood; 2000 Oct; 96(8):2649-54. PubMed ID: 11023494
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection.
Didigu CA; Wilen CB; Wang J; Duong J; Secreto AJ; Danet-Desnoyers GA; Riley JL; Gregory PD; June CH; Holmes MC; Doms RW
Blood; 2014 Jan; 123(1):61-9. PubMed ID: 24162716
[TBL] [Abstract][Full Text] [Related]
40. CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue.
Penn ML; Grivel JC; Schramm B; Goldsmith MA; Margolis L
Proc Natl Acad Sci U S A; 1999 Jan; 96(2):663-8. PubMed ID: 9892690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
